Stem Cell Transplant Results Better than Standard Therapy in Severe Scleroderma Patients, Phase 2 Trial Shows – Scleroderma News
Scleroderma News |
Stem Cell Transplant Results Better than Standard Therapy in Severe Scleroderma Patients, Phase 2 Trial Shows
Scleroderma News Results from a Phase 2 clinical trial shows that stem cell transplants can provide better long-term benefits than the standard treatment for patients with severe scleroderma. Myeloablative autologous hematopoietic stem cell transplant, which uses high … |
